Performance of Deauville Criteria in
[18F]FDG-PET/CT
deauville criteria
giant cell arteritis
inter-rater agreement
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
03 Jan 2023
03 Jan 2023
Historique:
received:
27
11
2022
revised:
28
12
2022
accepted:
29
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
9
1
2023
Statut:
epublish
Résumé
In this retrospective study, PET/CT data from 59 patients with suspected giant cell arteritis (GCA) were reviewed using the Deauville criteria to determine an optimal cut-off between PET positivity and negativity. Seventeen standardised vascular regions were analysed per patient by three investigators blinded to clinical information. Statistical analysis included ROC curves with areas under the curve (AUC), Cohen's and Fleiss' kappa (κ) to calculate sensitivity, specificity, accuracy, and agreement. According to final clinician's diagnosis and the revised 2017 ACR criteria GCA was confirmed in 29 of 59 (49.2 %) patients. With a diagnostic cut-off ≥ 4 (highest tracer uptake of a vessel wall exceeds liver uptake) for PET positivity, all investigators achieved high accuracy (range, 89.8-93.2%) and AUC (range, 0.94-0.97). Sensitivity and specificity ranged from 89.7-96.6% and 83.3-96.7%, respectively. Agreement between the three investigators suggested 'almost perfect agreement' (Fleiss' κ = 0.84) A Deauville score of ≥4 as threshold for PET positivity yielded excellent results with high accuracy and almost perfect inter-rater agreement, suggesting a standardized, reproducible, and reliable score in diagnosing GCA. However, the small sample size and reference standard could lead to biases. Therefore, verification in a multicentre study with a larger patient cohort and prospective setting is needed.
Identifiants
pubmed: 36611449
pii: diagnostics13010157
doi: 10.3390/diagnostics13010157
pmc: PMC9818714
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Blood. 2018 Nov 22;132(21):2273-2279
pubmed: 30166329
Br J Gen Pract. 2012 Jun;62(599):329-30
pubmed: 22687229
Am J Nucl Med Mol Imaging. 2019 Dec 15;9(6):255-273
pubmed: 31976156
J Nucl Cardiol. 2014 Jun;21(3):588-97
pubmed: 24633502
Eur J Nucl Med. 1999 Apr;26(4):333-41
pubmed: 10199938
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
PLoS One. 2016 Mar 10;11(3):e0149072
pubmed: 26963909
Ann Rheum Dis. 2018 May;77(5):636-643
pubmed: 29358285
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):155-66
pubmed: 24008434
Arthritis Rheum. 1999 Feb;42(2):311-7
pubmed: 10025926
Nuklearmedizin. 2013;52(4):148-56
pubmed: 23928982
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Leuk Lymphoma. 2009 Aug;50(8):1257-60
pubmed: 19544140
Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii32-ii42
pubmed: 29982778
Rheumatology (Oxford). 2017 Apr 1;56(4):506-515
pubmed: 27481272
J Nucl Med. 2018 Jul;59(7):1167-1169
pubmed: 29626118
Ann Oncol. 2011 May;22(5):1198-1203
pubmed: 20966182
N Engl J Med. 2017 Jul 27;377(4):317-328
pubmed: 28745999
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Biomed Res Int. 2015;2015:914692
pubmed: 25695092
Nat Rev Dis Primers. 2022 Jan 6;7(1):93
pubmed: 34992251
Nat Rev Rheumatol. 2022 Jan;18(1):22-34
pubmed: 34853411
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):249-258
pubmed: 26280981
Z Rheumatol. 2016 Nov;75(9):924-931
pubmed: 26704559
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):369-83
pubmed: 24271038
BMC Med. 2017 Jun 28;15(1):120
pubmed: 28655311
Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):344-53
pubmed: 22072285
N Engl J Med. 2015 Apr 23;372(17):1598-607
pubmed: 25901426
Rheumatology (Oxford). 1999 May;38(5):444-7
pubmed: 10371283
Eur J Nucl Med Mol Imaging. 2003 May;30(5):730-6
pubmed: 12677302
Ann Nucl Med. 2021 May;35(5):557-568
pubmed: 33683545
Arthritis Rheum. 1990 Aug;33(8):1122-8
pubmed: 2202311
J Clin Rheumatol. 2011 Sep;17(6):306-10
pubmed: 21869711
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii5-iii16
pubmed: 32348512
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1250-1269
pubmed: 29637252
Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):674-81
pubmed: 15747154
J Nucl Med. 2013 May;54(5):683-90
pubmed: 23516309
AJR Am J Roentgenol. 2017 Aug;209(2):270-276
pubmed: 28463521
N Engl J Med. 2016 Jun 23;374(25):2419-29
pubmed: 27332902
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3886-3902
pubmed: 33942141
J Nucl Med. 2008 Jul;49(7):1107-13
pubmed: 18552151
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1764-72
pubmed: 21559981
Medicine (Baltimore). 2015 Apr;94(14):e622
pubmed: 25860208
Vasc Med. 2008;13(2):127-40
pubmed: 18593802